1
|
Nagore D, Candela A, Bürge M, Tamayo E, Murie-Fernández M, Vives M, Monedero P, Álvarez J, Mendez E, Pasqualetto A, Mon T, Pita R, Varela MA, Esteva C, Pereira MA, Sanchez J, Rodriguez MA, Garcia A, Carmona P, López M, Pajares A, Vicente R, Aparicio R, Gragera I, Calderón E, Marcos JM, Gómez L, Rodríguez JM, Matilla A, Medina A, Hernández A, Morales L, Santana L, Garcia E, Montesinos S, Muñoz P, Bravo B, Blanco V. Uric acid and acute kidney injury in high-risk patients for developing acute kidney injury undergoing cardiac surgery: A prospective multicenter study. Rev Esp Anestesiol Reanim (Engl Ed) 2024:S2341-1929(24)00094-5. [PMID: 38704092 DOI: 10.1016/j.redare.2024.04.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/17/2023] [Revised: 09/06/2023] [Accepted: 09/20/2023] [Indexed: 05/06/2024]
Abstract
PURPOSE It is unclear whether preoperative serum uric acid (SUA) elevation may play a role in the development of acute kidney injury (AKI) associated with cardiac surgery (CSA-AKI). We conducted a cohort study to evaluate the influence of preoperative hyperuricemia on AKI in patients at high risk for developing SC-AKI. DESIGN Multicenter prospective international cohort study. SETTING Fourteen university hospitals in Spain and the United Kingdom. PARTICIPANTS We studied 261 consecutive patients at high risk of developing CSA-AKI, according to a Cleveland score ≥ 4 points, from July to December 2017. INTERVENTIONS None. MEASUREMENTS AND MAIN RESULTS AKIN criteria were used for the definition of AKI. Multivariable logistic regression models and propensity score-matched pairwise analysis were used to determine the adjusted association between preoperative hyperuricemia (≥7 mg/dL) and AKI. Elevated preoperative AUS (≥7 mg/dL) was present in 190 patients (72.8%), whereas CSA-AKI occurred in 145 patients (55.5%). In multivariable logistic regression models, hyperuricemia was not associated with a significantly increased risk of AKI (adjusted Odds Ratio [OR]: 1.58; 95% confidence interval [CI]: 0.81-3; P = .17). In propensity score-matched analysis of 140 patients, the hyperuricemia group experienced similar adjusted odds of AKI (OR 1.05, 95%CI 0.93-1.19, P = .37). CONCLUSIONS Hyperuricemia was not associated with an increased risk of AKI in this cohort of patients undergoing cardiac surgery at high risk of developing CSA-AKI.
Collapse
Affiliation(s)
- D Nagore
- Departamento de Anestesia y Medicina Perioperatoria, Grupo Quirón - Policlínica Guipúzcoa, San Sebastián, Spain; Departamento de Anestesiología y Medicina Perioperatoria, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
| | - A Candela
- Departamento de Anestesia y Medicina Perioperatoria, Grupo Quirón - Policlínica Guipúzcoa, San Sebastián, Spain; Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitario Ramón y Cajal, Madrid, Spain
| | - M Bürge
- Departamento de Anestesia y Medicina Perioperatoria, Barts Heart Centre, St Bartholomew's Hospital, Londres, UK
| | - E Tamayo
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
| | | | - M Vives
- Departamento de Anestesiología & Cuidados Intensivos, Clínica Universidad de Navarra, Pamplona, Spain; Departamento de Anestesiología y Cuidados Intensivos, Clínica Universidad de Navarra, Pamplona, Spain.
| | - P Monedero
- Departamento de Anestesiología & Cuidados Intensivos, Clínica Universidad de Navarra, Pamplona, Spain
| | - J Álvarez
- Departamento de Anestesiología y Medicina Perioperatoria, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain; Departamento de Anestesiología y Medicina Perioperatoria, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain
| | - E Mendez
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain
| | - A Pasqualetto
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain
| | - T Mon
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain
| | - R Pita
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Alvaro Cunqueiro Vigo, Vigo, Spain
| | - M A Varela
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Alvaro Cunqueiro Vigo, Vigo, Spain
| | - C Esteva
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Alvaro Cunqueiro Vigo, Vigo, Spain
| | - M A Pereira
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Alvaro Cunqueiro Vigo, Vigo, Spain
| | - J Sanchez
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitario Central de Asturias, Oviedo, Spain
| | - M A Rodriguez
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitario Central de Asturias, Oviedo, Spain
| | - A Garcia
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - P Carmona
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitari i Politécnic La Fe, Valencia, Spain
| | - M López
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitari i Politécnic La Fe, Valencia, Spain
| | - A Pajares
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitari i Politécnic La Fe, Valencia, Spain
| | - R Vicente
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitari i Politécnic La Fe, Valencia, Spain
| | - R Aparicio
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitari i Politécnic La Fe, Valencia, Spain
| | - I Gragera
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Infanta Cristina, Badajoz, Spain
| | - E Calderón
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitario Puerta de Mar, Cádiz, Spain
| | - J M Marcos
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitario de León, León, Spain
| | - L Gómez
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitario Virgen del Rocio, Sevilla, Spain
| | - J M Rodríguez
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitario de Salamanca, Salamanca, Spain
| | - A Matilla
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitario de Salamanca, Salamanca, Spain
| | - A Medina
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitario de Málaga, Málaga, Spain
| | - A Hernández
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Policlínica Ibiza, Ibiza, Spain
| | - L Morales
- Servicio de Anestesiología y Medicina Perioperatoria, Hospital Universitario Dr, Negrín, Las Palmas de Gran Canaria, Spain
| | - L Santana
- Servicio de Anestesiología y Medicina Perioperatoria, Hospital Universitario Dr, Negrín, Las Palmas de Gran Canaria, Spain
| | - E Garcia
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | - S Montesinos
- Departamento de Anestesiología y Medicina Perioperatoria, Centro Médico Teknon Barcelona, Barcelona, Spain
| | - P Muñoz
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital 12 de octubre, Madrid, Spain
| | - B Bravo
- Servicio de Anestesiología y Medicina Perioperatoria, Hospital de Cruces de Bizkaia, Bilbao, Spain
| | - V Blanco
- Departamento de Anestesiología y Medicina Perioperatoria, Hospital Universitario Virgen de la Macarena, Sevilla, Spain
| |
Collapse
|
2
|
López E, Sánchez-Margallo FM, Álvarez V, Blázquez R, Marinaro F, Abad A, Martín H, Báez C, Blanco V, Crisóstomo V, Casado JG. Identification of very early inflammatory markers in a porcine myocardial infarction model. BMC Vet Res 2019; 15:91. [PMID: 30898123 PMCID: PMC6427889 DOI: 10.1186/s12917-019-1837-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2018] [Accepted: 03/05/2019] [Indexed: 01/17/2023] Open
Abstract
BACKGROUND Acute myocardial infarction (AMI) is one of the most deleterious conditions leading to cardiovascular diseases and mortality. The importance of an early and accurate diagnosis assures immediate medical treatments, which are fundamental to reduce mortality and improve prognoses. AMI is associated to an inflammatory response which includes the increase of circulating inflammatory cytokines, chemokines and immune cell activation. This study aimed to identify which are the very early immune-related biomarkers that may be used as predictors of myocardial infarction severity. In order to mimic the pathophysiological events involved in human myocardial infarction, a temporary occlusion (90 min) of the mid-left anterior descending coronary artery was performed in a swine animal model. RESULTS Lymphocyte subsets analysis in peripheral blood revealed significant alterations in CD4+/CD8+ ratio and naïve and effector/memory T cell percentages at 1 h post-myocardial infarction. Changes in TH1/TH2-related cytokine, monocyte and neutrophil markers gene expression were observed in peripheral blood lymphocytes, as well. Additionally, significant correlations between cardiac parameters (cardiac enzymes, left ventricular ejection fraction and % infarct) and blood-derived parameters (cytokine expression and lymphocyte subset distribution) were found. CONCLUSIONS Peripheral blood lymphocyte alterations are easily and swiftly detectable, so they may be good biomarkers for a very early prognosis and to predict myocardial infarction severity.
Collapse
Affiliation(s)
- Esther López
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain
| | - Francisco Miguel Sánchez-Margallo
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain
- CIBER de Enfermedades Cardiovasculares, 28029 Madrid, Spain
| | - Verónica Álvarez
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain
| | - Rebeca Blázquez
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain
- CIBER de Enfermedades Cardiovasculares, 28029 Madrid, Spain
| | - Federica Marinaro
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain
| | - Ana Abad
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain
| | - Helena Martín
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain
| | - Claudia Báez
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain
- CIBER de Enfermedades Cardiovasculares, 28029 Madrid, Spain
| | - Virginia Blanco
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain
- CIBER de Enfermedades Cardiovasculares, 28029 Madrid, Spain
| | - Verónica Crisóstomo
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain
- CIBER de Enfermedades Cardiovasculares, 28029 Madrid, Spain
| | - Javier García Casado
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain
- CIBER de Enfermedades Cardiovasculares, 28029 Madrid, Spain
| |
Collapse
|
3
|
Quattrocolo F, D'Ambrosio A, Blanco V, Voglino G, Clemente S, Camussi E, Martorana M, Zotti CM. Prevalence of healthcare associated infections and antibiotic use in Piedmont’s acute care hospitals. Eur J Public Health 2018. [DOI: 10.1093/eurpub/cky212.551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- F Quattrocolo
- Department of Public Health and Pediatric Sciences, University of Turin, Turin, Italy
| | - A D'Ambrosio
- Department of Public Health, University of Turin, Turin, Italy
| | - V Blanco
- Department of Public Health, University of Turin, Turin, Italy
| | - G Voglino
- Department of Public Health, University of Turin, Turin, Italy
| | - S Clemente
- Department of Public Health, University of Turin, Turin, Italy
| | - E Camussi
- Department of Public Health, University of Turin, Turin, Italy
| | - M Martorana
- Department of Public Health, University of Turin, Turin, Italy
| | - CM Zotti
- Department of Public Health, University of Turin, Turin, Italy
| |
Collapse
|
4
|
Blázquez R, Álvarez V, Antequera-Barroso JA, Báez-Díaz C, Blanco V, Maestre J, Moreno-Lobato B, López E, Marinaro F, Casado JG, Crisóstomo V, Sánchez-Margallo FM. Altered hematological, biochemical and immunological parameters as predictive biomarkers of severity in experimental myocardial infarction. Vet Immunol Immunopathol 2018; 205:49-57. [PMID: 30459001 DOI: 10.1016/j.vetimm.2018.10.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2018] [Revised: 10/09/2018] [Accepted: 10/19/2018] [Indexed: 11/30/2022]
Abstract
Preclinical studies in cardiovascular medicine are necessary to translate basic research to the clinic. The porcine model has been widely used to understand the biological mechanisms involved in cardiovascular disorders for which purpose different closed-chest models have been developed in the last years to mimic the pathophysiological events seen in human myocardial infarction. In this work, we studied hematological, biochemical and immunological parameters, as well as Magnetic resonance derived cardiac function measurements obtained from a swine myocardial infarction model. We identified some blood parameters which were significantly altered after myocardial infarction induction. More importantly, these parameters (gamma-glutamyl transferase, glutamic pyruvic transaminase, red blood cell counts, hemoglobin concentration, hematocrit, platelet count and plateletcrit) correlated positively with cardiac function, infarct size and/or cardiac enzymes (troponin I and creatine kinase-MB). Thus several blood-derived parameters have allowed us to predict the severity of myocardial infarction in a clinically relevant animal model. Therefore, here we provide a simple, affordable and reliable way that could prove useful in the follow up of myocardial infarction and in the evaluation of new therapeutic strategies in this animal model.
Collapse
Affiliation(s)
- Rebeca Blázquez
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, 10071, Spain; CIBER de Enfermedades Cardiovasculares, Madrid, 28029, Spain.
| | - Verónica Álvarez
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, 10071, Spain.
| | | | - Claudia Báez-Díaz
- CIBER de Enfermedades Cardiovasculares, Madrid, 28029, Spain; Endoluminal Therapy and Diagnosis Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, 10071, Spain.
| | - Virginia Blanco
- CIBER de Enfermedades Cardiovasculares, Madrid, 28029, Spain; Endoluminal Therapy and Diagnosis Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, 10071, Spain.
| | - Juan Maestre
- CIBER de Enfermedades Cardiovasculares, Madrid, 28029, Spain; Endoluminal Therapy and Diagnosis Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, 10071, Spain.
| | - Beatriz Moreno-Lobato
- Animal Modelling Service, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, 10071, Spain.
| | - Esther López
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, 10071, Spain.
| | - Federica Marinaro
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, 10071, Spain.
| | - Javier G Casado
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, 10071, Spain; CIBER de Enfermedades Cardiovasculares, Madrid, 28029, Spain.
| | - Verónica Crisóstomo
- CIBER de Enfermedades Cardiovasculares, Madrid, 28029, Spain; Endoluminal Therapy and Diagnosis Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, 10071, Spain.
| | - Francisco Miguel Sánchez-Margallo
- Stem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, 10071, Spain; CIBER de Enfermedades Cardiovasculares, Madrid, 28029, Spain.
| |
Collapse
|
5
|
Rodríguez-Pintó I, Espinosa G, Erkan D, Shoenfeld Y, Cervera R, Cervera R, Espinosa G, Rodríguez-Pintó I, Shoenfeld Y, Erkan D, Piette JC, Jacek M, Roca B, Tektonidou M, Moutsopoulos H, Boffa J, Chapman J, Stojanovich L, Veloso MP, Praprotnik S, Traub B, Levy R, Daryl T, Daryl T, Boffa MC, Makatsaria A, Ruano M, Allievi A, You W, Khamastha M, Hughes S, Menendez Suso J, Pacheco J, Boriotti MF, Dias C, Pangtey G, Miller S, Policepatil S, Larissa L, Marjatta S, Carolyn S, Noortje T, Reiner K, Arteaga S, Leilani T, Langsford D, Niedzwiecki M, Queyrel V, Moroti-Constantinescu R, Romero C, Jeremic K, Urbano A, Hurtado-García R, Kumar Das A, Costedoat-Chalumeau N, Yngvar F, Gomez-Puerta JA, de Meigs E, Smith JP, Zakharova E, Nayer A, Douglas W, Lyndsey R, Blanco V, Vicent C, Natalya K, Damian L, Valentini E, Giula B, Casal Moura M, Araújo Loperena O, Ritter Susan Y, Guettrot Imbert G, Almasri H, Hospach T, Mouna B, Robles A, Wilson H, Guisado P, Ruiz R, Rodriguez J. The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients. Rheumatology (Oxford) 2018; 57:1264-1270. [DOI: 10.1093/rheumatology/key082] [Citation(s) in RCA: 43] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2017] [Revised: 02/28/2018] [Indexed: 01/19/2023] Open
Affiliation(s)
| | - Gerard Espinosa
- Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain
| | - Doruk Erkan
- Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, New York, NY, USA
| | - Yehuda Shoenfeld
- Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Aviv, Israel
| | - Ricard Cervera
- Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Vaccarezza M, Agustinho A, Alberti MJ, Argumedo L, Armeno M, Blanco V, Bouquet C, Cabrera A, Caraballo R, Caramuta L, Cresta A, de Grandis ES, DeMartini MG, Diez C, Diz M, Dlugoszewski C, Escobal N, Ferrero H, Galicchio S, Gambarini V, Gamboni B, Gonzalez L, Guisande S, Hassan A, Matarrese P, Mestre G, Pesce L, Rios V, Semprino M, Sosa P, Toma M, Viollaz R, Panico L. [National consensus on the modified Atkins diet]. Rev Neurol 2016; 62:371-376. [PMID: 27064917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
INTRODUCTION Epilepsy is a chronic disease that affects 0.5-1% of the population. One third of the patients become refractory to antiepileptic drugs. Among the non-pharmacological treatments available, the modified Atkins diet is an effective treatment used since 2003 as another alternative for children and adults with refractory epilepsy. DEVELOPMENT The Ketogenic Diet National Committee, which depends on the Argentine Society of Pediatric Neurology, elaborated this consensus on the modified Atkins diet, basing itself on a review of the literature and on their clinical experience. This consensus in Spanish explains the different aspects to be taken into account regarding the modified Atkins diet, patient selection, implementation, different controls and adverse effects. Unlike the classic ketogenic diet, the modified Atkins diet is initiated without fasting or hospital stay, nor does it require protein, calorie or fluid restriction, thus improving patient palatability and consequently patient tolerability. CONCLUSIONS The modified Atkins diet is a useful treatment for patients with intractable epilepsy. The publication of this consensus offers the possibility for new centers to get oriented regarding this diet implementation.
Collapse
Affiliation(s)
| | - Ariela Agustinho
- Hospital Nacional de Pediatria J. P. Garrahan, 1818 Buenos Aires, Argentina
| | | | - Laura Argumedo
- Hospital de Ninos Santisima Trinidad, Cordoba, Argentina
| | - Marisa Armeno
- Hospital Nacional de Pediatria J. P. Garrahan, 1818 Buenos Aires, Argentina
| | | | - Cecilia Bouquet
- Hospital Nacional Profesor Alejandro Posadas, Buenos Aires, Argentina
| | | | - Roberto Caraballo
- Hospital Nacional de Pediatria J. P. Garrahan, 1818 Buenos Aires, Argentina
| | - Luciana Caramuta
- Hospital Nacional Profesor Alejandro Posadas, Buenos Aires, Argentina
| | - Araceli Cresta
- Hospital Nacional de Pediatria J. P. Garrahan, 1818 Buenos Aires, Argentina
| | | | | | - Cecilia Diez
- Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - Mariana Diz
- Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | | | - Nidia Escobal
- Hospital Nacional de Pediatria J. P. Garrahan, 1818 Buenos Aires, Argentina
| | - Hilario Ferrero
- Hospital Privado de Comunidad, 7600 Mar de Plata (Buenos Aires), Argentina
| | | | - Victoria Gambarini
- Hospital Privado de Comunidad, 7600 Mar de Plata (Buenos Aires), Argentina
| | - Beatriz Gamboni
- Hospital Pediatrico Doctor Humberto J. Notti, Mendoza, Argentina
| | | | - Silvina Guisande
- Hospital Nacional Profesor Alejandro Posadas, Buenos Aires, Argentina
| | - Amal Hassan
- Hospital Pediatrico Doctor Humberto J. Notti, Mendoza, Argentina
| | | | - Graciela Mestre
- Hospital Nacional de Pediatria J. P. Garrahan, 1818 Buenos Aires, Argentina
| | - Laura Pesce
- Hospital de Ninos Sor Maria Ludovica, La Plata, Argentina
- Hospital Pediatrico Doctor Humberto J. Notti, Mendoza, Argentina
| | - Viviana Rios
- Hospital de Ninos Doctor Orlando Alassia, Santa Fe, Argentina
| | | | - Patricia Sosa
- Hospital Nacional Profesor Alejandro Posadas, Buenos Aires, Argentina
| | - Marisol Toma
- Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - Rocío Viollaz
- Hospital de Ninos Sor Maria Ludovica, La Plata, Argentina
| | - Luis Panico
- Hospital de Ninos Doctor Orlando Alassia, Santa Fe, Argentina
| |
Collapse
|
7
|
Crisostomo V, Baez-Diaz C, Blanco V, Maestre J, Mangas T, Palacios I, Steendam R, Hiemstra C, Franssen O, Sanchez F. INTRACORONARY ADMINISTRATION OF MICROENCAPSULATED INSULIN-LIKE GROWTH FACTOR 1 IMPROVES CARDIAC FUNCTION IN A SWINE MODEL OF ACUTE MYOCARDIAL INFARCTION. J Am Coll Cardiol 2016. [DOI: 10.1016/s0735-1097(16)30158-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
8
|
Vaccarezza Ferrari M, Agustinho A, Alberti MJ, Argumedo L, Armeno M, Blanco V, Bouquet C, Cabrera A, Caraballo RH, Caramuta L, Cresta A, De Grandis ES, Demartini MG, Díez C, Diz M, Dlugoszewski C, Escobal N, Ferrero H, Galicchio S, Gambarini V, Gamboni B, González L, Guisande S, Hassan A, Matarrese P, Mestre G, Pesce L, Ríos V, Semprino M, Sosa P, Toma M, Viollaz R, Panico LR. Consenso nacional de dieta Atkins modificada. Rev Neurol 2016. [DOI: 10.33588/rn.6208.2015447] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
9
|
Alberti MJ, Agustinho A, Argumedo L, Armeno M, Blanco V, Bouquet C, Cabrera A, Caraballo R, Caramuta L, Cresta A, de Grandis ES, De Martini MG, Diez C, Dlugoszewski C, Escobal N, Ferrero H, Galicchio S, Gambarini V, Gamboni B, Guisande S, Hassan A, Matarrese P, Mestre G, Pesce L, Ríos V, Sosa P, Vaccarezza M, Viollaz R, Panico L. Recommendations for the clinical management of children with refractory epilepsy receiving the ketogenic diet. ARCH ARGENT PEDIATR 2015; 114:56-63. [PMID: 26914076 DOI: 10.5546/aap.2016.eng.56] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2015] [Accepted: 09/18/2015] [Indexed: 11/12/2022]
Abstract
The ketogenic diet, a non-drug treatment with proven effectiveness, has been the most commonly used therapy in the past decade for the management of refractory epilepsy in the pediatric population. Compared to adding a new drug to a pre-existing treatment, the ketogenic diet is highly effective and reduces the number of seizures by 50-90% in approximately 45-60% of children after six months of treatment. For this reason, the Argentine Society of Pediatric Neurology established the Ketogenic Diet Working Group. It is integrated by pediatric dietitians, pediatricians, pediatric neurologists and B.S. in Nutrition, who developed recommendations for the optimal management of patients receiving the classical ketogenic diet based on expert consensus and scientific publications in this field.
Collapse
Affiliation(s)
- María J Alberti
- Hospital Interzonal de Agudos Especializados en Pediatría "Sor María Ludovica", La Plata, Buenos Aires, B1904CSI, Argentina.
| | - Ariela Agustinho
- Hospital de Pediatría S.A.M.I.C. "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos Aires, C1245AAM, Argentina
| | - Laura Argumedo
- Hospital Pediátrico "Dr Humberto J. Notti", Mendoza, 5519, Argentina
| | - Marisa Armeno
- Hospital de Pediatría S.A.M.I.C. "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos Aires, C1245AAM, Argentina
| | - Virginia Blanco
- Fundación Hospital de Niños "Victor J. Vilela", Rosario, Santa Fe, S2002LPC, Argentina
| | - Cecilia Bouquet
- Hospital Nacional Posadas, El Palomar, Buenos Aires, 1684, Argentina
| | - Analía Cabrera
- Fundación Hospital de Niños "Victor J. Vilela", Rosario, Santa Fe, S2002LPC, Argentina
| | - Roberto Caraballo
- Hospital de Pediatría S.A.M.I.C. "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos Aires, C1245AAM, Argentina
| | - Luciana Caramuta
- Hospital Nacional Posadas, El Palomar, Buenos Aires, 1684, Argentina
| | - Araceli Cresta
- Hospital de Pediatría S.A.M.I.C. "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos Aires, C1245AAM, Argentina
| | | | | | - Cecilia Diez
- Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, C1181ACH, Argentina
| | - Corina Dlugoszewski
- Hospital de Niños "Dr. Ricardo Gutiérrez", Ciudad Autónoma de Buenos Aires, C1425EFD, Argentina
| | - Nidia Escobal
- Hospital de Pediatría S.A.M.I.C. "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos Aires, C1245AAM, Argentina
| | - Hilario Ferrero
- Hospital Privado de Comunidad, Mar del Plata, Buenos Aires, B7602CBM, Argentina
| | - Santiago Galicchio
- Fundación Hospital de Niños "Victor J. Vilela", Rosario, Santa Fe, S2002LPC, Argentina
| | - Victoria Gambarini
- Hospital de Niños "Dr. Ricardo Gutiérrez", Ciudad Autónoma de Buenos Aires, C1425EFD, Argentina
| | - Beatriz Gamboni
- Hospital Pediátrico "Dr Humberto J. Notti", Mendoza, 5519, Argentina
| | - Silvina Guisande
- Hospital Nacional Posadas, El Palomar, Buenos Aires, 1684, Argentina
| | - Amal Hassan
- Hospital Pediátrico "Dr Humberto J. Notti", Mendoza, 5519, Argentina
| | - Pablo Matarrese
- Hospital Interzonal de Agudos Especializados en Pediatría "Sor María Ludovica", La Plata, Buenos Aires, B1904CSI, Argentina
| | - Graciela Mestre
- Hospital de Pediatría S.A.M.I.C. "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos Aires, C1245AAM, Argentina
| | - Laura Pesce
- Hospital Pediátrico "Dr Humberto J. Notti", Mendoza, 5519, Argentina
| | - Viviana Ríos
- Hospital de Niños "Dr. Orlando Alassia", Santa Fe, S3000CII, Argentina
| | - Patricia Sosa
- Hospital Nacional Posadas, El Palomar, Buenos Aires, 1684, Argentina
| | - María Vaccarezza
- Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, C1181ACH, Argentina
| | - Rocío Viollaz
- Hospital Interzonal de Agudos Especializados en Pediatría "Sor María Ludovica", La Plata, Buenos Aires, B1904CSI, Argentina
| | - Luis Panico
- Hospital de Niños "Dr. Orlando Alassia", Santa Fe, S3000CII, Argentina
| |
Collapse
|
10
|
Qi X, Blanco V, Chu Z, Vallabhapurapu S, Sulaiman M, Franco R. P-040 Phosphatidylserine Targeted Therapy of Pancreatic Cancer Using SapC-DOPS Nanovesicles. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv233.40] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
11
|
Otero P, Smit F, Cuijpers P, Torres A, Blanco V, Vázquez FL. Long-term efficacy of indicated prevention of depression in non-professional caregivers: randomized controlled trial. Psychol Med 2015; 45:1401-1412. [PMID: 25331992 DOI: 10.1017/s0033291714002505] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND Although depression is a common problem among non-professional caregivers, only one trial has evaluated the efficacy of indicated prevention targeting this population and the long-term efficacy is unknown. The aim of this study was to evaluate the long-term efficacy of a brief intervention for the indicated prevention of depression in a sample of female caregivers. METHOD A randomized controlled trial was conducted involving 173 participants (mean age 53.9 years) who were allocated to the intervention (n = 89) or the usual-care control group (n = 84). Blinded interviewers conducted assessments at 1, 3, 6 and 12 months of follow-up. The main outcome measure was the incidence of major depression and the secondary outcomes were compliance with treatment, depressive symptoms, emotional distress and caregiver burden. RESULTS At the 12-month follow-up, a lower incidence of depression as evaluated using the Structured Clinical Interview for Axis I Disorders of the DSM-IV was found in the intervention group compared with the control group (10.1% v. 25.0%). The relative risk was 0.40 and statistically significant [χ2 = 6.68, degrees of freedom = 1, p = 0.010, 95% confidence interval (CI) 0.20-0.81], and the number needed to treat was 7 (95% CI 4-27). There was a significant delay in the onset of depression in the intervention group (p = 0.008). The good complier caregivers had a lower incidence of depression. The intervention effect on depressive symptoms, emotional distress and caregiver burden were maintained for 12 months. CONCLUSIONS This is the first study to demonstrate that a brief problem-solving intervention can prevent the onset of depression among non-professional caregivers over the longer term.
Collapse
Affiliation(s)
- P Otero
- Department of Clinical Psychology and Psychobiology,Unit of Depressive Disorders, University of Santiago de Compostela,Santiago de Compostela,Spain
| | - F Smit
- Department of Clinical Psychology and EMGO Institute for Health and Care Research, VU University,Amsterdam,The Netherlands
| | - P Cuijpers
- Department of Clinical Psychology and EMGO Institute for Health and Care Research, VU University,Amsterdam,The Netherlands
| | - A Torres
- Department of Psychiatry, Radiology and Public Health,University of Santiago de Compostela,Santiago de Compostela,Spain
| | - V Blanco
- Department of Clinical Psychology and Psychobiology,Unit of Depressive Disorders, University of Santiago de Compostela,Santiago de Compostela,Spain
| | - F L Vázquez
- Department of Clinical Psychology and Psychobiology,University of Santiago de Compostela,Santiago de Compostela,Spain
| |
Collapse
|
12
|
Weintraub AS, Blanco V, Barnes M, Green RS. Impact of renal function and protein intake on blood urea nitrogen in preterm infants in the first 3 weeks of life. J Perinatol 2015; 35:52-6. [PMID: 25078864 DOI: 10.1038/jp.2014.138] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/07/2014] [Revised: 06/19/2014] [Accepted: 06/26/2014] [Indexed: 11/09/2022]
Abstract
OBJECTIVE To examine the relationship between blood urea nitrogen (BUN) during the first 3 weeks of life and protein intake and creatinine (Cr) and to quantify the effect of protein intake on postnatal growth in preterm infants. STUDY DESIGN This is a 4-year, single-center, retrospective cohort study. We used multivariable linear regression models to examine the relationships between mean weekly BUN and protein intake adjusted for mean weekly Cr and potential confounders. We used additional regression models to examine the effect of protein intake on growth during this period. RESULT Overall, 249 infants met study criteria. As protein intake increased over the first 3 weeks of life, both BUN and Cr decreased significantly. Linear regression models showed protein intake and Cr were each significantly associated with mean BUN for each study week. CONCLUSION Protein intake and Cr were each significantly associated with BUN. Significant amelioration of growth failure was seen with higher protein intake.
Collapse
Affiliation(s)
- A S Weintraub
- 1] Mount Sinai Medical Center, Division of Newborn Medicine, Department of Pediatrics, Kravis Children's Hospital, New York, NY, USA [2] Department of Pediatrics, The Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - V Blanco
- Department of Pediatrics, The Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - M Barnes
- Department of Pediatrics, The Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - R S Green
- 1] Mount Sinai Medical Center, Division of Newborn Medicine, Department of Pediatrics, Kravis Children's Hospital, New York, NY, USA [2] Department of Pediatrics, The Icahn School of Medicine at Mount Sinai, New York, NY, USA
| |
Collapse
|
13
|
Blanco V, Chu Z, Vallabhapurapu S, Sulaiman M, Kendler A, Curry R, Warnick R, Franco R, Qi X. NT-06 * PHOSPHATIDYLSERINE-SELECTIVE TARGETING AND ANTICANCER EFFECTS OF SapC-DOPS NANOVESICLES ON BRAIN TUMORS. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou265.6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
14
|
Sulaiman MK, Blanco V, Chu Z, Valabhurapu S, Franco R, Qi X. CS-32 * SapC-DOPS INDUCES Smac-AND Bax-MEDIATED MITOCHONDRIAL APOPTOSIS IN NEUROBLASTOMAS. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou242.32] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
15
|
Armeno M, Caraballo R, Vaccarezza M, Alberti MJ, Ríos V, Galicchio S, de Grandis ES, Mestre G, Escobal N, Matarrese P, Viollaz R, Agostinho A, Díez C, Cresta A, Cabrera A, Blanco V, Ferrero H, Gambarini V, Sosa P, Bouquet C, Caramuta L, Guisande S, Gamboni B, Hassan A, Pesce L, Argumedo L, Dlugoszewski C, DeMartini MG, Panico L. [National consensus on the ketogenic diet]. Rev Neurol 2014; 59:213-223. [PMID: 25156026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
INTRODUCTION Epilepsy is a chronic disease with onset in infancy affecting 0.5-1% of the population. One third of the patients is refractory to antiepileptic drugs and they pose a challenge for the health care team. The ketogenic diet is an effective, non-pharmacological, alternative treatment for the management of refractory epilepsy. AIMS There is a need to establish guidelines for the adequate and increased use of the ketogenic diet in Spanish-speaking countries. The National Committee on the Ketogenic Diet, consisting of paediatric neurologists, clinical nutritionists, and dietitians, of the Argentine Society of Child Neurology has developed this consensus statement to standardize the use of the ketogenic diet based on the literature and clinical experience. DEVELOPMENT Patient selection, pre-treatment family counseling, drug interactions, micronutrient supplementation, adverse effects, and discontinuation of the diet are discussed. CONCLUSIONS The ketogenic diet is an effective treatment for children with refractory epilepsy. Education and collaboration of the patient and their family is essential. The patient should be managed by an experienced multidisciplinary team using a protocol. The formation of a national multidisciplinary team and the publication of this document provide possibilities for new centers to integrate the ketogenic diet into their treatment options.
Collapse
Affiliation(s)
| | - Roberto Caraballo
- Hospital de Pediatria SAMIC. Prof. Dr. J.P. Garrahan, Buenos Aires, Argentina
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Armeno M, Caraballo RH, Vaccarezza Ferrari M, Alberti MJ, Ríos V, Galicchio S, De Grandis ES, Mestre G, Escobal N, Matarrese P, Viollaz R, Agostinho A, Díez C, Cresta A, Cabrera A, Blanco V, Ferrero H, Gambarini V, Sosa P, Bouquet C, Caramuta L, Guisande S, Gamboni B, Hassan A, Pesce L, Argumedo L, Dlugoszewski C, Demartini MG, Panico LR. Consenso nacional sobre dieta cetogénica. Rev Neurol 2014. [DOI: 10.33588/rn.5905.2014277] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
17
|
Arias S, Bruzzone I, Blanco V, Inchausti M, García F, Casavieja G, Silveira R, Ruiz Díaz ME, Belmonte S. [Identification and early nutritional support in hospitalized malnourished patients]. NUTR HOSP 2008; 23:348-353. [PMID: 18604321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2007] [Accepted: 11/14/2007] [Indexed: 05/26/2023] Open
Abstract
INTRODUCTION The prevalence of hyponutrition in hospitalized patients in our setting is 53%. The therapeutic approach is controversial. OBJECTIVES To determine whether an early nutritional intervention in hospitalized patients by means of oral nutritional support can improve their prognosis regarding decreased morbimortality and hospital stay. MATERIAL AND METHODS Randomized prospective study comprised by a treatment group and a control group of malnourished patients hospitalized at the Internal Medicine and Respiratory Medicine Departments. The nutritional diagnosis was made by using the Subjective Global Assessment. Groups B and C were assigned to receive the hospital diet according to their needs and pathology (control group) and the treatment group also received a standard nutritional supplement. We recorded the development of infections, pressure ulcers, hospitalization days, mortality, and weight. RESULTS We performed more than 1,700 Subjective Global Assessments. Five hundred and thirty seven patients (264 treated and 273 controls) were followed-up until hospital discharge or death. We did not find statistically significant differences in mortality, hospital stay, or occurrence of complications between the treatment group and the control group. The treatment group presented statistically significant weight increase as compared with the control group. CONCLUSIONS We could not demonstrate benefits when using the oral nutritional supplement in terms of mortality, hospital stay, infectious complications, or pressure ulcers. The significant weight increase in the treatment group allowed us concluding that the supplement effectively treated hyponutrition in this group. This new clinical status implies a better prognosis, as it has already been shown. However, this could not be observed by means of the study parameters. Long-term studies are required to determine for how long this nutritional improvement can be sustained, implying a better prognosis in the long run.
Collapse
Affiliation(s)
- S Arias
- Clínica Médica 3, Hospital Maciel, Montevideo, Uruguay.
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Parga J, Rodriguez-Pallares J, Blanco V, Guerra MJ, Labandeira-Garcia JL. Different effects of anti-sonic hedgehog antibodies and the hedgehog pathway inhibitor cyclopamine on generation of dopaminergic neurons from neurospheres of mesencephalic precursors. Dev Dyn 2008; 237:909-17. [DOI: 10.1002/dvdy.21481] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
19
|
Blanco V, Lopez Camelo J, Carri NG. Growth inhibition, morphological differentiation and stimulation of survival in neuronal cell type (Neuro-2a) treated with trophic molecules. Cell Biol Int 2002; 25:909-17. [PMID: 11518498 DOI: 10.1006/cbir.2001.0775] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Trophic molecules are key regulators of survival, growth and differentiation of neural cells. Neuronal cell type Neuro-2a is a good model to study development and molecules modulating this process, and retinoic acid (RA) and neurotrophins (NGF, BDNF, NT-3 and NT-4) have been shown to be active in this modulation. The purpose of the present study was the functional analysis of these trophic molecules in our short-term bioassay of Neuro-2a cells, an immortalised murine neuroblastoma cell line. Through cell counting, image process and arithmetic combination of digital parameters of treated and untreated cultures, we show that RA inhibits growth and induces morphological neuronal phenotype of treated cells. Through DNA labelling with BrdU we also show that NGF, BDNF, and NT-3 increase survival and proliferation of cells, grown in serum-deprived media. From these results we conclude that neurotrophins have manifest trophic effects on cells improving survival, growth and proliferation and we also confirm the growth arrest and differentiation properties of RA on Neuro-2a cells.
Collapse
Affiliation(s)
- V Blanco
- Molecular Biology, IMBICE, CC 403, 1900 La Plata, Argentina
| | | | | |
Collapse
|
20
|
Ryder MI, Pons B, Adams D, Beiswanger B, Blanco V, Bogle G, Donly K, Hallmon W, Hancock EB, Hanes P, Hawley C, Johnson L, Wang HL, Wolinsky L, Yukna R, Polson A, Carron G, Garrett S. Effects of smoking on local delivery of controlled-release doxycycline as compared to scaling and root planing. J Clin Periodontol 1999; 26:683-91. [PMID: 10522780 DOI: 10.1034/j.1600-051x.1999.261008.x] [Citation(s) in RCA: 48] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
This paper examines the effects of smoking on the treatment outcomes of two nonsurgical therapies: (1) scaling and root planing alone (SRP) or (2) controlled-release of subgingivally delivered doxycycline hyclate in a polylactic acid based polymer gel. Subjects from 2 9-month multicenter studies were classified as nonsmokers (never smoked: 100 subjects), former smokers (137 subjects), and current smokers (> or = 10 cigarettes/day: 121 subjects). Clinical parameters were analyzed for treated sites with baseline probing depths > or = 5 mm and for a subset of treated sites with baseline probing depths of > or = 7 mm. Clinical parameters (plaque levels, clinical attachment levels, pocket depths, and bleeding on probing) were analyzed at baseline, 4, 6, and 9 months. In the doxycycline treated group in general, there were neither marked significant differences in clinical attachment gain nor differences in probing depth reduction among the 3 smoking groups. On the other hand, in the scaling and root planing treated group in general, there were significant differences in clinical attachment gain and pocket depth reduction, with non-smokers responding better than former smokers and current smokers at 6 and 9 months. These differences in clinical response between scaling and root planing alone versus controlled-release of locally-delivered doxycycline hyclate among these 3 smoking groups are discussed in relation to treatment implications for smokers.
Collapse
Affiliation(s)
- M I Ryder
- University of California San Francisco/School of Dentistry, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Abstract
Abstract
Normal values for 13 chemical constituents of plasma were estimated from results for 837 presumably healthy children. Ninety microliters of specimen was analyzed for lactate dehydrogenase, aspartate aminotransferase, alkaline phosphatase, inorganic phosphorus, total calcium, total cholesterol, total proteins, albumin, uric acid, urea nitrogen, alanine aminotransferase, total bilirubin, and glucose. We used two Abbott ABA-100 Bichromatic Analyzers interfaced directly to the ABA Data Management System. For each test age- and sex-related variations were assessed and normal values were estimated for six different age groups.
Collapse
|
22
|
Cheng MH, Lipsey AI, Blanco V, Wong HT, Spiro SH. Microchemical analysis for 13 constituents of plasma from healthy children. Clin Chem 1979; 25:692-8. [PMID: 436235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Normal values for 13 chemical constituents of plasma were estimated from results for 837 presumably healthy children. Ninety microliters of specimen was analyzed for lactate dehydrogenase, aspartate aminotransferase, alkaline phosphatase, inorganic phosphorus, total calcium, total cholesterol, total proteins, albumin, uric acid, urea nitrogen, alanine aminotransferase, total bilirubin, and glucose. We used two Abbott ABA-100 Bichromatic Analyzers interfaced directly to the ABA Data Management System. For each test age- and sex-related variations were assessed and normal values were estimated for six different age groups.
Collapse
|